At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,026 enrolled
Drug / intervention
No interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Healthy Human Global Project - Hong Kong: A Community-based Cross-sectional Study on Genetic and Environmental Determinants of Immune Phenotype Variance in a Healthy Asian Population - Establishing a Path Towards Personalized Medicine
In Brief
An observational study evaluating No intervention for Healthy and Immune System and Related Disorders. Completed, enrolled 1,026 participants across 1 site.
Detailed Summary
The Healthy Human Global Project-Hong Kong aims to elucidate the heritable and non-heritable factors that drive immunological variance within a healthy population in Hong Kong. By gaining a deeper understanding of these parameters, a path can be paved for personalised and precision medicine, tailored for an Asian population.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy, Immune System and Related Disorders
CountriesChina
CollaboratorsThe University of Hong Kong, Institut Pasteur
Timeline
N/ACompletedFinished
20222023202420252026
First PostedJan 2022
Enrollment StartJul 2022
Primary CompletionSep 2023
TodayJul 2026
First PostedJan 3, 2022
Enrollment StartJul 1, 2022
Primary CompletionSep 14, 2023
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 4.5 years ago
Interventions
No interventionother
No intervention